NASDAQ:ACHV

Achieve Life Sciences (ACHV) Stock Price, News & Analysis

$4.41
-0.10 (-2.22%)
(As of 04/22/2024 ET)
Today's Range
$4.35
$4.58
50-Day Range
$3.82
$4.67
52-Week Range
$3.03
$10.30
Volume
82,081 shs
Average Volume
88,134 shs
Market Capitalization
$151.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.25

Achieve Life Sciences MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
291.2% Upside
$17.25 Price Target
Short Interest
Bearish
2.09% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.37mentions of Achieve Life Sciences in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.94) to ($0.88) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.55 out of 5 stars

Medical Sector

669th out of 910 stocks

Biotechnology Industry

5th out of 13 stocks

ACHV stock logo

About Achieve Life Sciences Stock (NASDAQ:ACHV)

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

ACHV Stock Price History

ACHV Stock News Headlines

Achieve Life Sciences (NASDAQ:ACHV) Now Covered by Jonestrading
Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
ACHV: 2023 Results
Q4 2023 Achieve Life Sciences Inc Earnings Call
Recap: Achieve Life Sciences Q4 Earnings
ACHV Apr 2024 2.500 call
How AI Is Saving Lives
See More Headlines
Receive ACHV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/28/2024
Today
4/22/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ACHV
CUSIP
68230A10
Employees
22
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.25
High Stock Price Target
$20.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+291.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-29,820,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.07) per share

Miscellaneous

Free Float
33,567,000
Market Cap
$151.04 million
Optionable
Optionable
Beta
1.32
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Richard A. B. Stewart (Age 65)
    Executive Chairman
    Comp: $575k
  • Mr. John A. Bencich M.B.A. (Age 47)
    CEO & Director
    Comp: $733.12k
  • Dr. Cindy Jacobs M.D. (Age 66)
    Ph.D., President, Chief Medical Officer & Director
    Comp: $614.25k
  • Mr. Jerry Wan (Age 42)
    Principal Accounting Officer
  • Dr. Anthony Clarke (Age 68)
    Chief Scientific Officer
    Comp: $546k
  • Ms. Jaime Xinos
    Executive Vice President of Commercial

ACHV Stock Analysis - Frequently Asked Questions

Should I buy or sell Achieve Life Sciences stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Achieve Life Sciences in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACHV shares.
View ACHV analyst ratings
or view top-rated stocks.

What is Achieve Life Sciences' stock price target for 2024?

4 Wall Street analysts have issued 1 year price targets for Achieve Life Sciences' shares. Their ACHV share price targets range from $11.00 to $20.00. On average, they anticipate the company's share price to reach $17.25 in the next twelve months. This suggests a possible upside of 291.2% from the stock's current price.
View analysts price targets for ACHV
or view top-rated stocks among Wall Street analysts.

How have ACHV shares performed in 2024?

Achieve Life Sciences' stock was trading at $4.12 at the beginning of the year. Since then, ACHV shares have increased by 7.0% and is now trading at $4.41.
View the best growth stocks for 2024 here
.

When is Achieve Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our ACHV earnings forecast
.

How were Achieve Life Sciences' earnings last quarter?

Achieve Life Sciences, Inc. (NASDAQ:ACHV) announced its earnings results on Thursday, March, 28th. The biopharmaceutical company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.32) by $0.06.

What ETF holds Achieve Life Sciences' stock?

Simplify Propel Opportunities ETF holds 217,845 shares of ACHV stock, representing 0.94% of its portfolio.

When did Achieve Life Sciences' stock split?

Shares of Achieve Life Sciences reverse split before market open on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Achieve Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), KushCo (KSHB) and Pennsylvania Real Estate Investment Trust (PEI).

How do I buy shares of Achieve Life Sciences?

Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACHV) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners